Prolonged survival and probable cure in chronic myelogenous leukemia.
Gabor
E P
EP
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D012074:Remission Induction
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D006918:Hydroxyurea